Your session is about to expire
← Back to Search
Best Systemic Therapy (BST) + Surgery or Radiation Therapy for Prostate Cancer
Study Summary
This trial is testing whether adding surgery or radiation to hormone therapy is more effective at controlling prostate cancer.
- Prostate Cancer
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Has the FDA ratified a combination of Best Systemic Therapy (BST) plus Surgery or Radiation Therapy?
"The safety of Best Systemic Therapy (BST) + Surgery or Radiation Therapy has been assessed as a level 2 on our risk scale, as this is only a Phase 2 trial and there is evidence supporting its safety, but none suggesting its efficacy."
Do you have any open slots in this clinical experiment?
"According to clinicaltrials.gov, this particular trial is not presently enrolling patients. Originally posted on March 18th 2013 and last updated on May 4th 2022, although it does not need volunteers at the moment, there are over 1300 other studies recruiting participants currently."
In which locales is this investigation currently administered?
"Currently, 4 distinct medical centres are in the process of recruiting patients for this trial. These sites include University of Texas MD Anderson Cancer Center in Houston, Fox Chase Cancer Centre in Philadelphia, and Vancouver Prostate Center in Vancouver alongside a fourth undisclosed location."
Share this study with friends
Copy Link
Messenger